Entasis Therapeutics Holdings Operating Income

Entasis Therapeutics Holdings (ETTX) currently reports a operating income of $-89M as of March 2022. That compares with $-52M in the prior-year period — down 73.4% year over year. Use the charts on this page to explore Entasis Therapeutics Holdings's operating income history and peer comparisons.

Entasis Therapeutics Holdings's operating income decreased from $-52M to $-89M — a 73.4% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Entasis Therapeutics Holdings reported $-89M in operating income as of March 2022. That compares with $-52M in the prior-year period — down 73.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-89M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Entasis Therapeutics Holdings, and consider following ETTX for alerts when major investors trade the stock.

Entasis Therapeutics Holdings is classified in the Healthcare sector. On operating income, it currently shows $-89M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ETTX with unrelated industries.